ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)

Q: What does CUSIP 00166B105 represent in this 13F holders report?

CUSIP 00166B105 is the security identifier for ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share in Q4 2023?

93 institutional investors reported ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share for Q4 2023. Use the holders table for investor-level position and value details.

CUSIP: 00166B105

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 132,496,020
Total 13F shares: 45,764,823
Share change: +10,735,580
Total reported value: $681,456,826
Put/Call ratio: 26%
Price per share: $14.89
Number of holders: 93
Value change: +$185,269,081
Number of buys: 62
Number of sells: 31

Quarterly Holders Quick Answers

What is CUSIP 00166B105?
CUSIP 00166B105 identifies ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 00166B105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
LSV Associates, LLC	3/4/5	10%+ Owner	— class O/S missing	4,526,963	$61,575,751	—	13 Dec 2021	3/4/5
venBio Partners LLC	13F	Company	7.3%	9,699,925	$46,559,640	—	30 Sep 2023	13F
FMR LLC	13F	Company	4.2%	5,591,947	$26,841,345	—	30 Sep 2023	13F
Vivo Capital, LLC	13F	Company	3.2%	4,220,048	$20,256,230	—	30 Sep 2023	13F
ORBIMED ADVISORS LLC	13F	Company	2.2%	2,871,000	$13,780,800	—	30 Sep 2023	13F
BlackRock Finance, Inc.	13F	Company	1.4%	1,843,019	$8,846,491	—	30 Sep 2023	13F
Redmile Group, LLC	13F	Company	0.97%	1,283,289	$6,159,787	—	30 Sep 2023	13F
BRAIDWELL LP	13F	Company	0.94%	1,249,900	$5,999,520	—	30 Sep 2023	13F
VANGUARD GROUP INC	13F	Company	0.76%	1,008,236	$4,839,533	—	30 Sep 2023	13F
Logos Global Management LP	13F	Company	0.75%	1,000,000	$4,800,000	—	30 Sep 2023	13F
Cormorant Asset Management, LP	13F	Company	0.46%	612,079	$2,937,979	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.33%	443,067	$2,126,953	—	30 Sep 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.32%	425,217	$2,041,041	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	0.29%	389,359	$1,868,923	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	0.25%	333,483	$1,600,718	—	30 Sep 2023	13F
FEDERATED HERMES, INC.	13F	Company	0.19%	251,360	$1,206,528	—	30 Sep 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.16%	212,500	$1,020,000	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	0.14%	191,524	$919,315	—	30 Sep 2023	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.11%	146,677	$704,050	—	30 Sep 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.11%	140,734	$675,523	—	30 Sep 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.1%	134,739	$647,038	—	30 Sep 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.1%	131,127	$629,409	—	30 Sep 2023	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.07%	94,400	$453,120	—	30 Sep 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.07%	87,653	$420,734	—	30 Sep 2023	13F
Bank of New York Mellon Corp	13F	Company	0.05%	72,050	$345,840	—	30 Sep 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.04%	52,084	$250,003	—	30 Sep 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	51,748	$248,390	—	30 Sep 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	50,957	$244,587	—	30 Sep 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.04%	48,500	$232,800	—	30 Sep 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.03%	45,682	$219,274	—	30 Sep 2023	13F
MARTINGALE ASSET MANAGEMENT L P	13F	Company	0.03%	44,609	$214,124	—	30 Sep 2023	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.03%	41,000	$203,000	—	30 Sep 2023	13F
Nan Fung Group Holdings Ltd	13F	Company	0.03%	41,950	$201,360	—	30 Sep 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	40,290	$193,392	—	30 Sep 2023	13F
CORNERCAP INVESTMENT COUNSEL INC	13F	Company	0.03%	35,071	$168,341	—	30 Sep 2023	13F
HSBC HOLDINGS PLC	13F	Company	0.03%	35,404	$168,169	—	30 Sep 2023	13F
Financial Advisory Group	13F	Company	0.02%	31,417	$150,802	—	30 Sep 2023	13F
ALPS ADVISORS INC	13F	Company	0.02%	30,358	$145,718	—	30 Sep 2023	13F
BARCLAYS PLC	13F	Company	0.02%	26,964	$129,428	—	30 Sep 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.02%	21,735	$104,328	—	30 Sep 2023	13F
J.P. Morgan Private Wealth Advisors LLC	13F	Company	0.02%	20,000	$96,000	—	30 Sep 2023	13F
BOURGEON CAPITAL MANAGEMENT LLC	13F	Company	0.01%	19,570	$93,936	—	30 Sep 2023	13F
Trexquant Investment LP	13F	Company	0.01%	14,269	$68,491	—	30 Sep 2023	13F
ZACKS INVESTMENT MANAGEMENT	13F	Company	0.01%	13,918	$66,807	—	30 Sep 2023	13F
Forefront Analytics, LLC	13F	Company	0.01%	13,769	$66,092	—	30 Sep 2023	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	12,918	$62,006	—	30 Sep 2023	13F
Verition Fund Management LLC	13F	Company	0.01%	11,649	$55,915	—	30 Sep 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.01%	11,600	$55,680	—	30 Sep 2023	13F
UBS Group AG	13F	Company	0.01%	11,194	$53,731	—	30 Sep 2023	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	10,900	$52,320	—	30 Sep 2023	13F

Institutional Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q4 2023

As of 31 Dec 2023, ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,764,823 shares. The largest 10 holders included venBio Partners LLC, FMR LLC, Vivo Capital, LLC, Redmile Group, LLC, Cormorant Asset Management, LP, ORBIMED ADVISORS LLC, BlackRock Inc., Vestal Point Capital, LP, VANGUARD GROUP INC, and MPM BioImpact LLC. This page lists 93 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

Q4 2023 holders

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.